Neumora Therapeutics
NMRA
#10166
Rank
HK$0.47 B
Marketcap
HK$2.51
Share price
-13.37%
Change (1 day)
-87.52%
Change (1 year)

EPS for Neumora Therapeutics (NMRA)

EPS in 2026 (TTM): -HK$9.60

According to Neumora Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$9.65. In 2025 the company made an earnings per share (EPS) of -HK$11.38 an increase over its 2024 EPS that were of -HK$12.00.

EPS history for Neumora Therapeutics from 2024 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-HK$9.60-15.6%
2025-HK$11.38-5.23%
2024-HK$12.00